The effect of carnitine supplementation in valproic acid (VPA) treated patients presenting with hyperammonemia was investigated in 69 children and young adults seen at the Zentrum der Kinderheilkunde, Goethe-Universitat Frankfurt, and Universitat Erlanger, FRG.